Company intelligence / Profile preview

Norn Group

San Francisco, California, United Statesnorn.group ↗

Ownership: Private
Development stage: Preclinical

Overview

Norn Group is a nonprofit focused on accelerating the development of therapies that slow or reverse human aging. It supports research infrastructure, talent programs, collaborative platforms like Longevity Nexus, and funding initiatives such as Impetus Grants. The group does not directly run clinical trials but aims to maximize the probability that by 2060 there will be interventions allowing people to live much longer in good health.

Therapeutic areas: Other
Modalities: Gene therapySmall moleculeBiologic
Industry: Academic Hospital/University/Research

Partnerships

Impetus GrantsAmaranth Foundation

Beyond the preview

Go deeper on Norn Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norn Group.

Explore the full profile